Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Keros Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +7 vs. Q4 2021
- Shares held
- 16.4M
- +269.1K (+1.7%) vs. Q4 2021
- Total value
- $893.0M
- −$51.5M (−5.5%) vs. Q4 2021
- New holders
- 14
- 38 more added
- Sold out
- 7
- 24 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KROS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 132 | $198.6M |
| Q1 2026 | 151 | $205.6M |
| Q4 2025 | 166 | $408.4M |
| Q3 2025 | 155 | $558.0M |
| Q2 2025 | 139 | $479.6M |
| Q1 2025 | 156 | $428.6M |
| Q4 2024 | 161 | $582.1M |
| Q3 2024 | 164 | $2.03B |
| Q2 2024 | 152 | $1.44B |
| Q1 2024 | 147 | $2.08B |
| Q4 2023 | 121 | $1.02B |
| Q3 2023 | 107 | $730.6M |
| Q2 2023 | 123 | $901.0M |
| Q1 2023 | 129 | $937.0M |
| Q4 2022 | 126 | $948.2M |
| Q3 2022 | 113 | $680.1M |
| Q2 2022 | 104 | $479.7M |
| Q1 2022 | 106 | $893.0M |
| Q4 2021 | 99 | $944.5M |
| Q3 2021 | 89 | $545.4M |
| Q2 2021 | 80 | $599.7M |
| Q1 2021 | 83 | $887.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Keros Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 816,830 | $44.4M | 3.07% | +20,132+2.5% | Added |
| Alkeon Capital Management LLC | 906,433 | $49.3M | 0.22% | −20,000−2.2% | Reduced |
| BlackRock Inc. | 1,298,046 | $70.6M | 0.00% | +11,520+0.9% | Added |
| Deep Track Capital, LP | 1,380,306 | $75.1M | 4.85% | +80,306+6.2% | Added |
| OrbiMed Advisors LLC | 1,679,417 | $91.3M | 1.48% | 00.0% | Unchanged |
| FMR LLC | 3,007,936 | $163.6M | 0.01% | −496,862−14.2% | Reduced |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −111,500−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −63,028−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −3,981−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −3,455−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −214−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |